METROPOLITAN LIFE INSURANCE CO/NY - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,685
-50.3%
5,3300.0%0.00%0.0%
Q2 2023$25,531
+17.2%
5,330
+38.7%
0.00%0.0%
Q1 2023$21,784
-8.8%
3,842
-9.9%
0.00%0.0%
Q4 2022$23,878
-12.8%
4,2640.0%0.00%0.0%
Q3 2022$27,375
+460.8%
4,264
+199.6%
0.00%
Q2 2022$4,881
-85.3%
1,423
-69.5%
0.00%
-100.0%
Q1 2022$33,201
-71.1%
4,663
-66.2%
0.00%
-50.0%
Q4 2021$115,046
+66.0%
13,811
+38.7%
0.00%
+100.0%
Q3 2021$69,287
-85.1%
9,955
-48.9%
0.00%
-85.7%
Q2 2021$465,051
+51.9%
19,499
+31.1%
0.01%
+40.0%
Q1 2021$306,153
-20.1%
14,869
-4.9%
0.01%
-16.7%
Q4 2020$383,082
-13.5%
15,6360.0%0.01%
-25.0%
Q3 2020$442,655
+490.5%
15,636
-0.7%
0.01%
+700.0%
Q2 2020$74,960
-70.1%
15,748
+0.7%
0.00%
-50.0%
Q3 2017$251,000
+41.8%
15,6410.0%0.00%
+100.0%
Q2 2017$177,000
+5.4%
15,641
+14.3%
0.00%0.0%
Q3 2016$168,000
-57.4%
13,690
+1.0%
0.00%
-66.7%
Q2 2016$394,000
+129.1%
13,550
+109.5%
0.00%
+200.0%
Q1 2016$172,000
-24.2%
6,4670.0%0.00%
-50.0%
Q4 2015$227,0006,4670.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 14,378,802$342,935,0004.38%
SILVERARC CAPITAL MANAGEMENT, LLC 122,700$2,926,0001.30%
COMMODORE CAPITAL LP 145,453$3,469,0001.21%
Asymmetry Capital Management, L.P. 63,259$1,509,0001.04%
Opaleye Management Inc. 250,000$5,963,0000.99%
Ikarian Capital, LLC 500,000$11,924,0000.96%
HighVista Strategies LLC 44,750$1,068,0000.76%
SILVERARC CAPITAL MANAGEMENT, LLC 63,915$1,524,0000.68%
Altium Capital Management LP 104,626$2,495,0000.58%
Integral Health Asset Management, LLC 75,000$1,789,0000.49%
View complete list of SERES THERAPEUTICS INC shareholders